Install
Biotech
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
- 9 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
- Aerospace
- Agriculture
- Banking (Industry)
- Computing
- Consumer Goods
- Defense
- Energy & Utilities
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Real Estate (Commercial)
- Management & Consulting
- Manufacturing
- Technology
- Telecom
- Transportation & Logistics
- Automotive
- Construction
- Education & EdTech
- Hospitality & Travel
- Insurance (Industry)
- Mining & Materials
- Pharmaceuticals
Latest in Biotech
BioConsortia Appoints Matthew Mouw as Vice President of Business Development - AOL
3+ day, 11+ hour ago (632+ words) BioConsortia, Inc., a microbial discovery and development company advancing high-performance biological solutions for global agriculture, today announced the appointment of Matthew Mouw as Vice... DAVIS, Calif.--(BUSINESS WIRE)--Sep 17, 2026-- BioConsortia, Inc., a microbial discovery and development company advancing high-performance biological…...
Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures
2+ hour, 11+ min ago (12+ words) Top news and commentary for technology's leaders, from all around the web....
Radiopharma companies merge after one receives surprise FDA rejection
4+ hour, 25+ min ago (148+ words) ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging in a deal worth at least $1.65 billion. Under the deal, Telix will acquire all shares of the privately held company ITM. Telix…...
Ultragenyx sets $3.95 million price for rare disease gene therapy
3+ day, 17+ hour ago (373+ words) Sept 17 (Reuters) - Ultragenyx Pharmaceutical said on Thursday it has set a U.S. list price of $3.95 million for its newly approved gene therapy Fayuvi, launching one of the world's most expensive drugs as a one-time treatment for a rare, fatal childhood disease....
Regulatory pressures, AI opportunities draw PE to life sciences software: 8 deals
1+ week, 2+ day ago (84+ words) Ardian, Bregal Sagemount, Riverside and Thoma Bravo are among the PE dealmakers targeting investments in the life sciences sofware market. A verification email is on its way to you. Please check your spam or junk folder just in case. Need…...
WBS Activity Coding Structure Simplifies Primavera P6 Schedules｜Himansi Kaur
1+ day, 22+ hour ago (184+ words) In Primavera P6, activity code refers to a label which is assigned to an activity. This label is based on a specific classification. For example, a building project may contain activities for excavation, foundations, structural work, electrical installation, and finishing. Without…...
US sanctions were meant to slow China’s tech industry. Instead, a 72% rise in science-linked patents reveals how restricted firms are building their own path to innovation
2+ day, 21+ hour ago (92+ words) Setback for Mamata as EC freezes TMC symbol gets football player symbol ‘Odisha holds immense potential in the semiconductor sector’: Vaishnaw DUSU elections: Safety, hostels, metro passes top ABVP-NSUI agenda HAL to deliver Tejas trainers & HTT-40 to IAF, Dhruv NG…...
Ride Therapeutics Secures Up To $7.3 Million From Cystic Fibrosis Foundation For AI-Designed Genetic Medicine Delivery
14+ hour, 51+ min ago (260+ words) Ride Therapeutics has secured a strategic investment commitment of up to $7.3 million from the Cystic Fibrosis Foundation to advance its Molecular Logistics platform for delivering genetic medicines to the lung. The funding will support the development of novel non-viral carriers…...
Frazier Life Sciences Raises More Than $1.1 Billion For Public Biotech Fund, Bringing Commitments To $2.8 Billion
15+ hour, 1+ min ago (283+ words) Frazier Life Sciences has raised more than $1.1 billion in new commitments for its Public Fund through an oversubscribed fundraising, bringing total committed capital for the strategy to approximately $2.8 billion. The fund focuses primarily on small- and mid-cap publicly traded biotechnology…...
Angle Health raises $200 million
16+ hour, 19+ min ago (213+ words) Angle Health has secured a $200 million Series C financing at a $2.7 billion valuation. The round was led by Vitruvian Partners, with participation from new investor Town Hall Ventures and existing investors Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator....